{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:47:29Z","timestamp":1761511649464},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,2,1]]},"DOI":"10.1038\/sj.bmt.1702107","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:38:33Z","timestamp":1031153913000},"page":"263-266","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The prophylactic potential of fludarabine monophosphate in graft-versus-host disease after bone marrow transplantation in murine models"],"prefix":"10.1038","volume":"25","author":[{"given":"R","family":"Or","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Amir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Tejman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Polliack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,2,8]]},"reference":[{"key":"BF1702107_CR1","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1056\/NEJM197504172921605","volume":"292","author":"ED Thomas","year":"1975","unstructured":"Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation New Engl J Med 1975 292: 832\u2013843","journal-title":"New Engl J Med"},{"key":"BF1702107_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S0952-7915(96)80085-9","volume":"8","author":"RA Nash","year":"1996","unstructured":"Nash RA, Storb R . Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL Curr Opin Immunol 1996 8: 674\u2013680","journal-title":"Curr Opin Immunol"},{"key":"BF1702107_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/0952-7915(93)90139-J","volume":"5","author":"JLM Ferrara","year":"1993","unstructured":"Ferrara JLM . Cytokine dysregulation as a mechanism of graft-versus-host disease Curr Opin Immunol 1993 5: 794\u2013799","journal-title":"Curr Opin Immunol"},{"key":"BF1702107_CR4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation Blood 1990 75: 555\u2013562","journal-title":"Blood"},{"key":"BF1702107_CR5","first-page":"155","volume":"6","author":"S Slavin","year":"1990","unstructured":"Slavin S, Ackerstein A, Naparstek E et al . The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD? Bone Marrow Transplant 1990 6: 155\u2013161","journal-title":"Bone Marrow Transplant"},{"key":"BF1702107_CR6","first-page":"51","volume":"8","author":"RL Truitt","year":"1991","unstructured":"Truitt RL, Atasoylu AA . Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of NHC-compatible bonemarrow Bone Marrow Transplant 1991 8: 51\u201358","journal-title":"Bone Marrow Transplant"},{"key":"BF1702107_CR7","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","volume":"300","author":"PL Weiden","year":"1979","unstructured":"Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts New Engl J Med 1979 300: 1068\u20131073","journal-title":"New Engl J Med"},{"key":"BF1702107_CR8","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1056\/NEJM198903303201303","volume":"320","author":"KM Sullivan","year":"1989","unstructured":"Sullivan KM, Storb R, Buckner CD et al. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms New Engl J Med 1989 320: 828\u2013834","journal-title":"New Engl J Med"},{"key":"BF1702107_CR9","first-page":"24","volume":"20","author":"A Pigaditou","year":"1993","unstructured":"Pigaditou A, Rohatiner AZS, Whelan JS et al. Fludarabine in low-grade lymphoma Semin Oncol 1993 20: (Suppl. 7) 24\u201327","journal-title":"Semin Oncol"},{"key":"BF1702107_CR10","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/S0140-6736(96)91681-5","volume":"347","author":"S Johnson","year":"1996","unstructured":"Johnson S, Smith AG, Loffler H et al. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocyte leukaemia. The French Cooperative Group on CLL Lancet 1996 347: 1432\u20131438","journal-title":"Lancet"},{"key":"BF1702107_CR11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood.V82.6.1695.1695","volume":"82","author":"S O'Brien","year":"1993","unstructured":"O'Brien S, Kantarjian H, Beran M et al. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment Blood 1993 82: 1695\u20131700","journal-title":"Blood"},{"key":"BF1702107_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1200\/JCO.1993.11.1.116","volume":"11","author":"V Gandhi","year":"1993","unstructured":"Gandhi V, Estey E, Kentin MJ, Plunkett W . Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy J Clin Oncol 1993 11: 116\u2013124","journal-title":"J Clin Oncol"},{"key":"BF1702107_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1600-0609.1993.tb00165.x","volume":"50","author":"PW Wijermans","year":"1993","unstructured":"Wijermans PW, Gerrits WB, Haak HL . Severe immunodeficiency in patients treated with fludarabine monophosphate Eur J Haematol 1993 50: 292\u2013296","journal-title":"Eur J Haematol"},{"key":"BF1702107_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2165\/00003495-199400476-00009","volume":"47","author":"G Dighiero","year":"1994","unstructured":"Dighiero G . Potential immunological action of purine nucleoside analogues Drugs 1994 47: (Suppl. 6) 57\u201362","journal-title":"Drugs"},{"key":"BF1702107_CR15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1182\/blood.V86.2.813.bloodjournal862813","volume":"86","author":"A Gratwohl","year":"1995","unstructured":"Gratwohl A, Hermans J, Apperley J et al. Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia Blood 1995 86: 813\u2013818","journal-title":"Blood"},{"key":"BF1702107_CR16","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1056\/NEJM199310213291703","volume":"329","author":"NJ Chao","year":"1993","unstructured":"Chao NJ, Schmidt GM, Niland JC et al. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease New Engl J Med 1993 329: 1225\u20131230","journal-title":"New Engl J Med"},{"key":"BF1702107_CR17","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood.V85.12.3746.bloodjournal85123746","volume":"85","author":"RA Nash","year":"1995","unstructured":"Nash RA, Etzioni R, Storb R et al. Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study Blood 1995 85: 3746\u20133753","journal-title":"Blood"},{"key":"BF1702107_CR18","first-page":"435","volume":"62","author":"ER Goodman","year":"1996","unstructured":"Goodman ER, Fiedor PS, Fein S et al. Fludarabine phosphate: a DNA synthesis inhibitor with potent immunosuppressive activity and minimal clinical toxicity Am Surg 1996 62: 435\u2013442","journal-title":"Am Surg"},{"key":"BF1702107_CR19","first-page":"229","volume":"6","author":"L Weiss","year":"1990","unstructured":"Weiss L, Reich S, Slavin S . Effect of cyclosporine A and methylprednisolone on the graft-versus-leukemia effects across major histocompatability barriers in mice following allogeneic bone marrow transplantation Bone Marrow Transplant 1990 6: 229\u2013233","journal-title":"Bone Marrow Transplant"},{"key":"BF1702107_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1200\/JCO.1991.9.1.175","volume":"9","author":"HG Chun","year":"1991","unstructured":"Chun HG, Leyland-Jones B, Cheson BD . Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies J Clin Oncol 1991 9: 175\u2013188","journal-title":"J Clin Oncol"},{"key":"BF1702107_CR21","first-page":"881","volume":"17","author":"J Mehta","year":"1996","unstructured":"Mehta J, Powles R, Singhal S et al. T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure Bone Marrow Transplant 1996 17: 881\u2013883","journal-title":"Bone Marrow Transplant"},{"key":"BF1702107_CR22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756\u2013763","journal-title":"Blood"},{"key":"BF1702107_CR23","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar N et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 1997 89: 4531\u20134536","journal-title":"Blood"},{"key":"BF1702107_CR24","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/sj.bmt.1701016","volume":"20","author":"J Kapelushnik","year":"1997","unstructured":"Kapelushnik J, Or R, Slavin S, Nagler A . A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia Bone Marrow Transplant 1997 20: 1109\u20131110","journal-title":"Bone Marrow Transplant"},{"key":"BF1702107_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0008-8749(90)90208-9","volume":"129","author":"T Priebe","year":"1990","unstructured":"Priebe T, Platsoucas CD, Seki H et al. Purine nucleoside modulation of functions of human lymphocytes Cell Immunol 1990 129: 321\u2013328","journal-title":"Cell Immunol"},{"key":"BF1702107_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1365-2141.1995.tb05300.x","volume":"91","author":"H Myint","year":"1995","unstructured":"Myint H, Coppelstone JA, Orchard J et al. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia Br J Haematol 1995 91: 341\u2013344","journal-title":"Br J Haematol"},{"key":"BF1702107_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-2141.1995.tb05311.x","volume":"91","author":"M Briz","year":"1995","unstructured":"Briz M, Cabrera R, Sanju\u00e1n I et al. Diagnosis of transfusion-associated graft-versus-host disease by polymerase chain reaction in fludarabine-treated B-chronic lymphocytic leukaemia Br J Haematol 1995 91: 409\u2013411","journal-title":"Br J Haematol"},{"key":"BF1702107_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2141.1995.tb08906.x","volume":"89","author":"GB Zulian","year":"1995","unstructured":"Zulian GB, Roux E, Tiercy JM et al. Transfusion-associated graft-versus-host disease in a patient treated with Cladribine (2-chlorodeoxyadenosine): demonstration of exogenous DNA in various tissue extracts by PCR analysis Br J Haematol 1995 89: 83\u201389","journal-title":"Br J Haematol"},{"key":"BF1702107_CR29","first-page":"737","volume":"93","author":"J Briones","year":"1996","unstructured":"Briones J, Pereira A, Alcorta I . Transfusion-associated graft-versus-host disease (TA-GVHD) in fludarabine-treated patients: is it time to irradiate blood component? Br J Haematol 1996 93: 737\u2013741","journal-title":"Br J Haematol"},{"key":"BF1702107_CR30","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V85.5.1207.bloodjournal8551207","volume":"85","author":"TH Lee","year":"1995","unstructured":"Lee TH, Donegan E, Slichter S, Busch MP . Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation Blood 1995 85: 1207\u20131214","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702107","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:58:17Z","timestamp":1648072697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2,1]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,2,1]]}},"alternative-id":["BF1702107"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702107","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2,1]]},"assertion":[{"value":"24 August 1998","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}